About Geistlich Pharma India Private Limited
Data last updated:
Geistlich Pharma India Private Limited is a foreign private limited company based in New Delhi, Delhi, India, a subsidiary of Geistlich Pharma Ag. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 28 November 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2015FTC287895. Its GSTIN is 07AAGCG1878F1ZI (Delhi).
The company has an authorised share capital of ₹2.7 Cr and a paid-up capital of ₹2.64 Cr. It is led by directors including Matthias Peter Hermann Dunkel and Jurg Reto Roth.
Its last annual general meeting (AGM) was held on 19 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit No. Dsm 162 On 1st Floor DLF Tower Shivaji Marg, New Delhi, Delhi, India – 110015.
As per the financials filed for FY 2025, the company reported a revenue of ₹15.83 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹1.1 Cr (net margin 6.9%) and EBITDA of ₹1.78 Cr (EBITDA margin 11.2%). Revenue has grown at a compounded annual rate (CAGR) of 27% over three years and 12% over five years.
The company has about 13 employees on its provident fund (EPFO) records.
Court records list 5 cases involving the company, including 5 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website geistlich.in.
Company details
Contact details
Geistlich Pharma India Private Limited's registered office is in New Delhi, Delhi. Its website is geistlich.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressUnit No. Dsm 162 On 1st Floor DLF Tower Shivaji Marg, New Delhi, Delhi, India – 110015
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Geistlich Pharma India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Geistlich Pharma India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Geistlich Pharma India Private Limited, buy the company report.
Financials of Geistlich Pharma India Private Limited
FY 2025 filings availableGeistlich Pharma India Private Limited reported revenue of ₹15.83 Cr (up 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 4% growth in the latest year. EBITDA rose 151% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.78 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.1 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.2% | ||||
| Net Profit Margin | 6.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Geistlich Pharma India Private Limited, buy the company report.
Board of directors of Geistlich Pharma India Private Limited
Geistlich Pharma India has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Matthias Peter Hermann Dunkel | Director | 26 Oct 2020 | 5 Years 11 Months | Current |
| Jurg Reto Roth | Director | 15 Jan 2018 | 8 Years 9 Months | Current |
| Prakash Virendra Kotak Also directs: Sunergos Consulting LLP, Bizerba India Private Limited, First Due Solutions India Private Limited and 5 more | Director | 28 Nov 2015 | 10 Years 10 Months | Current |
| Martin Rudolf Wartmann | Director | 19 Sep 2025 | 1 Years 1 Months | Current |
Auditor
Geistlich Pharma India Private Limited is audited by Price Waterhouse Chartered Accountants LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Price Waterhouse Chartered Accountants LLP | FY 2023 | 012754N/ N500016 |
Shareholding
The shareholding of Geistlich Pharma India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Geistlich Pharma India Private Limited, buy the company report.
Legal cases
Geistlich Pharma India Private Limited has 5 court cases on record: 5 filed by Geistlich Pharma India. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 0 | 0 |
| High courts | 1 | 0 | 0 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Writ petition | Filed by the company against The Commissioner of Central Tax Appeals-Ii, Delhi & Anr. | Disposed |
| District court, West, Delhi | Criminal case | Filed by the company against an individual | Disposed |
| District court, West, Delhi | Court case (RCA DJ) | Filed by the company against an individual | Disposed |
| District court, West, Delhi | Civil suit | Filed by the company against an individual | Disposed |
| District court, West, Delhi | Civil suit | Filed by the company against an individual | Disposed |
To see the full case history of Geistlich Pharma India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Geistlich Pharma India Private Limited has 3 MSME Form 1 returns on record for the period ending Mar 2017, listing 3 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Ambrane India Private Limited |
To see the full MSME payment records of Geistlich Pharma India Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Geistlich Pharma India Private Limited has a workforce of 13 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Geistlich Pharma India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAGCG1878F1ZI | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Geistlich Pharma India Private Limited, buy the company report.
Recent activity
Geistlich Pharma India Private Limited has 9 board changes on record since 2015: 4 appointments and 5 cessations. The latest: Martin Rudolf Wartmann was appointed as Director on 19 Sep 2025.
Frequently asked questions
Geistlich Pharma India is an active foreign private limited company based in New Delhi, Delhi, India. The company works in wholesale, within the trading industry. It was incorporated on 28 November 2015 (11+ years old) and is registered under CIN U74999DL2015FTC287895.
Geistlich Pharma India has 4 current directors:
- Matthias Peter Hermann Dunkel - Director
- Jurg Reto Roth - Director
- Prakash Virendra Kotak - Director
- Martin Rudolf Wartmann - Director
The latest financial statements of Geistlich Pharma India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 19 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Geistlich Pharma India is 07AAGCG1878F1ZI, registered in Delhi.
The CIN (Corporate Identification Number) of Geistlich Pharma India is U74999DL2015FTC287895. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Geistlich Pharma India has 5 court cases on record: 5 filed by the company. Most are in the district courts.
Geistlich Pharma India was incorporated on 28 November 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
Martin Rudolf Wartmann was appointed as Director on 19 Sep 2025. Matthias Peter Hermann Dunkel ceased to be Additional Director on 17 Sep 2021. Rolf Franz Jeger ceased to be Director on 30 Oct 2020. Geistlich Pharma India has 9 board changes on record in total.
Geistlich Pharma India has 3 MSME Form 1 returns on record for the period ending Mar 2017, listing 3 overdue payments to 1 micro and small supplier. The latest return was filed on 30 Oct 2019.
Geistlich Pharma India can be reached through the website geistlich.in. Its registered office is in New Delhi, Delhi, India.
The registered office of Geistlich Pharma India is at Unit No. Dsm 162 On 1st Floor DLF Tower Shivaji Marg, New Delhi, Delhi, India – 110015.